Tradestie Institutional Equity Comparison Engine
PLRZ vs RADX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PLRZ Overall Edge
PLRZ Captures Institutional Edge (2โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Polyrizon Ltd. Ordinary Shares (PLRZ) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, PLRZ trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus RADX at N/M Forward P/E and -411.6% operating margin (-36.9% YoY). In options structure, PLRZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PLRZ N/M vs RADX N/M Fwd P/E
Growth & Margin Winner
PLRZ
Op Margin 0.0% vs -411.6% ยท YoY +0.0% vs -36.9%
Momentum & Technical Winner
PLRZ
1Y +1226.8% vs -86.0% ยท 52W Pos 50% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PLRZ
NASDAQ
Polyrizon Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$9.31
-8.42% 1D
Market Cap
$24.7M
1M Return
+6.76%
1Y Return
+1226.78%
Forward P/E
N/M
Unified AI Score
31.2 / 100
SELL
Tech 15.0
Fund 34.0
Flow 50.0
Mom 40.0
RADX
NASDAQ
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
$0.63
-6.33% 1D
Market Cap
$10.6M
1M Return
-33.64%
1Y Return
-86.04%
Forward P/E
N/M
Unified AI Score
41.1 / 100
SELL
Tech 25.0
Fund 45.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PLRZ +1226.78%
RADX -86.04%
Spread: +1313.13 pp (PLRZ Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PLRZ TTM Op. Margin: 0.0%
RADX TTM Op. Margin: -411.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLRZ vs RADX. Trailing 12-month operating profitability (PLRZ 0.0% vs RADX -411.6%) and valuation multiples (PLRZ N/M vs RADX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PLRZ | RADX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $24.7M | $10.6M | Larger Scale | PLRZ |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -36.9% | Higher Growth | PLRZ |
| Operating Margin (TTM) Profitability | 0.0% | -411.6% | Higher Margin | PLRZ |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -21.4% | -174.7% | Higher ROE | PLRZ |
| 52-Week Range Position Momentum | 50% ($0โ$18) | 0% ($1โ$16) | Stronger Trend | PLRZ |
| Beta / 30D Volatility Risk Regime | 0.28ฮฒ ยท 86% Vol | 0.52ฮฒ ยท 109% Vol | Lower Realized Risk | PLRZ |
| Unified Institutional Score Composite Signal | 31.2 / 100 (SELL) | 41.1 / 100 (SELL) | Higher Composite | RADX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PLRZ vs RADX Buy Guide
PLRZ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
RADX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PLRZ nor RADX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.